Apical Efflux and Multidrug Resistance Transport

Why the Apical Transport Mechanism Matters

Renal secretion requires drug to reach the tubular lumen, but apical export is not one generic process. In proximal tubule cells, MATE1 and MATE2-K can exchange intracellular organic cations for luminal protons. P-glycoprotein (P-gp, ABCB1) and related ATP-binding cassette (ABC) transporters use ATP hydrolysis to drive substrate efflux. These mechanisms differ in their energy source and in how changes in luminal conditions can affect transport.

For a renal PBPK model, an apical efflux term should therefore reflect the transporter assigned to the substrate and the conditions under which the rate equation is used. A saturable outward-rate equation can be useful for both transporter classes, but that mathematical similarity does not make their mechanisms interchangeable. The distinction is especially important when luminal pH, intracellular substrate concentration, transporter abundance, or ATP availability changes.

Two Distinct Sources of Driving Force

MATE1 (SLC47A1) and kidney-enriched MATE2-K (SLC47A2) are proton-coupled organic cation transporters found at the apical membrane of renal proximal tubule cells. In a common mechanistic description, a proton moves from the lumen into the cell as an organic cation moves from the cell into the lumen. The inward proton gradient can thus drive outward cation transport. This is secondary active transport: the transporter uses an ion gradient rather than directly hydrolyzing ATP.

P-gp is an ABC transporter. It binds substrate and uses energy from ATP hydrolysis to support transport, often against a substrate concentration gradient. Other apical ABC transporters, including BCRP (ABCG2) and MRP-family transporters, also use ATP. Their substrate ranges differ; a drug should not be assigned to an apical transporter solely because it is a drug or because the transporter is expressed in the kidney.

The preceding material on basolateral organic cation uptake and membrane potential provides context for the intracellular substrate available to these apical pathways. Here the focus is the apical membrane step. A modeled apical rate does not alone establish the net rate of secretion from plasma into urine, which also depends on substrate delivery to the cell and processes in the tubular lumen.

Saturable Efflux as a Reduced PBPK Representation

When substrate is available at the intracellular face of a transporter, a common reduced representation of outward transport is a Michaelis–Menten rate:

Here \(V_{\max}\) is the maximum outward rate for the modeled cell population, and \(K_m\) is the intracellular unbound concentration at which this one-way rate is half of \(V_{\max}\). If \(J_{\mathrm{out}}\) is in nmol/min and concentration is in μM, \(V_{\max}\) is in nmol/min and \(K_m\) is in μM. Any scaling from a per-cell rate to a tissue-level rate must be applied consistently to \(V_{\max}\).

This equation is a reduced representation, not a complete transport cycle. Its rationale can be seen from a simple steady-state scheme: transporter \(E\) binds substrate \(C\) to form \(EC\), then releases substrate on the outward side. If binding is represented by \(E+C \rightleftharpoons EC\), and substrate release occurs at rate constant \(k_{\mathrm{cat}}\), the steady-state rate has the form \(k_{\mathrm{cat}}E_{\mathrm{tot}}C/(K_m+C)\), where \(K_m=(k_{\mathrm{off}}+k_{\mathrm{cat}})/k_{\mathrm{on}}\). Defining \(V_{\max}=k_{\mathrm{cat}}E_{\mathrm{tot}}\) gives the stated equation. For a real transporter with multiple binding and translocation steps, fitted \(K_m\) is an apparent kinetic parameter and need not equal a substrate binding affinity.

For MATE transport, this one-way form can be appropriate when the proton gradient is maintained in the outward-driving range and the model is intended to represent efflux under those specified conditions. A reduced model may make the dependence on that condition explicit:

The dimensionless \(f_{\mathrm{H}}\) is an empirical or experimentally specified factor for the proton conditions represented by the model. It should not be assumed to be a universal function of pH. If the proton gradient is dynamically modeled or can reverse, an irreversible outward-only rate can be inadequate: it can predict continued efflux even when the exchange conditions no longer favor outward transport.

For ABC transporters, a reduced equation can represent dependence on ATP explicitly when ATP is not effectively constant:

Here \(K_{\mathrm{ATP}}\) is an apparent ATP concentration parameter for the chosen model. If ATP is assumed to be nonlimiting and effectively constant, its contribution can be absorbed into \(V_{\max,\mathrm{ABC}}\). This equation remains a simplified rate law; it does not describe every molecular step of an ABC transport cycle.

Using the Proton Gradient to Check MATE Direction

A one-way Michaelis–Menten expression does not, by itself, test whether MATE exchange is thermodynamically directed outward. For a useful directional check, consider an idealized 1:1 exchange of a monovalent organic cation and a proton:

With equal positive charges exchanged, the electrical contributions to the free-energy change cancel in this idealized comparison. Using concentrations as approximations to activities, the free-energy change for the outward exchange is:

A negative \(\Delta G\) favors outward exchange; a positive value favors the reverse direction. The concentrations in the ratio must be expressed in consistent units. This idealized check states the direction implied by a specified exchange stoichiometry and gradient; it does not calculate the transporter’s rate. Actual transport can require more detailed kinetic and thermodynamic information.

Model Choice, Diagnostics, and Limitations

The appropriate model depends on which biological conditions the PBPK question needs to represent. A reduced, one-way saturable equation is compact when outward-driving conditions are maintained and the parameters are measured under comparable conditions. A proton-condition factor can represent a specified MATE condition without explicitly modeling proton dynamics. A reversible or more detailed exchange model is more appropriate when the proton gradient or luminal substrate may change enough to affect transport direction. For ABC transporters, ATP dependence may be explicit if ATP availability is expected to vary; otherwise, a constant-ATP approximation may be sufficient.

Useful diagnostics include checking that \(J_{\mathrm{out}}\) is zero when substrate concentration is zero, rises with \(C_{\mathrm{cell,u}}\), and approaches the intended maximum under saturating substrate conditions. Check units in every term: \(K_m\) must have the same concentration units as \(C_{\mathrm{cell,u}}\), and any ATP concentration must use the same units as \(K_{\mathrm{ATP}}\). For MATE, also check that an outward-only term is being used under conditions that support outward exchange. For ABC transport, confirm whether ATP dependence is explicit or already folded into \(V_{\max}\).

A common mistake is to call both MATE and P-gp “active efflux” and then give them the same mechanistic interpretation. The correction is to distinguish their energy sources: MATE-mediated cation export is coupled to proton movement, whereas P-gp and other ABC transporters use ATP hydrolysis. Both may be represented with saturable rate laws under suitable conditions, but similar equations do not establish the same driving force, substrate specificity, reversibility, or response to pH.

A second limitation is that a fitted apical \(V_{\max}\) or \(K_m\) may not uniquely identify transporter abundance, intrinsic turnover, and substrate affinity. In addition, an apical transporter term alone cannot establish how much drug appears in urine: filtration, basolateral delivery, other apical pathways, and luminal disposition also contribute. Parameters should therefore be interpreted in the context of the evidence and conditions used to estimate them.